Doug Besch

CIK: 0001947731

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (33.3%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)6 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OPRX

OptimizeRx Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

OPRX
OptimizeRx Corp
Dec 23, 2025
Tax Payment(F)
Direct
4.1K shares at avg. $12.74$52K
OPRX
OptimizeRx Corp
Dec 19, 2025
Exercise(M)
Direct
2K shares-
OPRX
OptimizeRx Corp
Dec 19, 2025
Tax Payment(F)
Direct
581 shares at avg. $13.51$8K
OPRX
OptimizeRx Corp
Oct 3, 2025
Exercise(M)
Direct
3.3K shares-
OPRX
OptimizeRx Corp
Oct 3, 2025
Tax Payment(F)
Direct
983 shares at avg. $18.75$18K
OPRX
OptimizeRx Corp
Aug 21, 2025
Award(A)
Direct
15.6K shares-
OPRX
OptimizeRx Corp
Feb 15, 2025
Tax Payment(F)
Direct
1.4K shares at avg. $6.64$9K
OPRX
OptimizeRx Corp
Dec 23, 2024
Award(A)
Direct
41.4K shares-
OPRX
OptimizeRx Corp
Dec 19, 2024
Exercise(M)
Direct
2K shares-
OPRX
OptimizeRx Corp
Dec 19, 2024
Tax Payment(F)
Direct
577 shares at avg. $4.75$3K
OPRX
OptimizeRx Corp
Oct 3, 2024
Exercise(M)
Direct
3.3K shares-
OPRX
OptimizeRx Corp
Oct 3, 2024
Tax Payment(F)
Direct
976 shares at avg. $7.83$8K

		Type	Shares	Price		Ownership
Dec 23, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	4,079	$12.74	$51,966	Direct
Dec 19, 2025	OPRX OptimizeRx Corp	Exercise(M)	1,964	-	-	Direct
Dec 19, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	581	$13.51	$7,849	Direct
Oct 3, 2025	OPRX OptimizeRx Corp	Exercise(M)	3,325	-	-	Direct
Oct 3, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	983	$18.75	$18,431	Direct
Aug 21, 2025	OPRX OptimizeRx Corp	Award(A)	15,625	-	-	Direct
Feb 15, 2025	OPRX OptimizeRx Corp	Tax Payment(F)	1,386	$6.64	$9,203	Direct
Dec 23, 2024	OPRX OptimizeRx Corp	Award(A)	41,408	-	$0	Direct
Dec 19, 2024	OPRX OptimizeRx Corp	Exercise(M)	1,964	-	$0	Direct
Dec 19, 2024	OPRX OptimizeRx Corp	Tax Payment(F)	577	$4.75	$2,741	Direct
Oct 3, 2024	OPRX OptimizeRx Corp	Exercise(M)	3,324	-	$0	Direct
Oct 3, 2024	OPRX OptimizeRx Corp	Tax Payment(F)	976	$7.83	$7,642	Direct

1-12 of 12 transactions

About Besch Doug

Besch Doug (SEC CIK 0001947731) files insider reports with the SEC as Chief Product Officer of OptimizeRx Corp (OPRX).

Signal8 holds 8 ownership filings by Besch Doug, all Form 4s, filed between Oct 7, 2024 and Dec 23, 2025. Those filings report 12 transactions, from Oct 3, 2024 to Dec 23, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Besch Doug's filings is in WALTHAM, MA.

Recent filings by Besch Doug

Dec 23, 2025: Tax withholding of OPRX shares (Form 4, code F).
Dec 19, 2025: Option exercise of OPRX shares (Form 4, code M).
Dec 19, 2025: Tax withholding of OPRX shares (Form 4, code F).
Oct 3, 2025: Option exercise of OPRX shares (Form 4, code M).
Oct 3, 2025: Tax withholding of OPRX shares (Form 4, code F).

Other insiders filing for OptimizeRx Corp (OPRX)

D'Silva Andrew J., Chief Business Officer
Silvestro Stephen L, Chief Executive Officer
Merrell Brendan W., CHIEF OPERATING OFFICER
Odence-Ford Marion, Chief Legal & Admin Officer
Stelmakh Edward, Chief Finance & Strat Officer
KLEMA CATHY, Director

How to read Form 4 transaction codes